Hemogenyx Pharmaceuticals Plc

HEMO.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-£6-£7-£4-£5
Dep. & Amort.£1£1£0£0
Deferred Tax£0£0£0-£0
Stock-Based Comp.£0£0£0£0
Change in WC£1-£1£0£0
Other Non-Cash£0£1£1£2
Operating Cash Flow-£4-£6-£3-£3
Investing Activities
PP&E Inv.-£0-£0-£0-£1
Net Acquisitions£0£0£0£0
Inv. Purchases£0£0-£0-£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.-£0£0£0£0
Investing Cash Flow-£0-£0-£0-£1
Financing Activities
Debt Repay.-£1-£1-£0-£3
Stock Issued£4£5£0£12
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.£0£0£0£0
Financing Cash Flow£3£4-£0£9
Forex Effect-£0£0-£1-£0
Net Chg. in Cash-£1-£1-£4£5
Supplemental Information
Beg. Cash£1£3£7£2
End Cash£0£1£3£7
Free Cash Flow-£4-£6-£3-£3